SPY301.56-1.41 -0.47%
DIA252.75-1.60 -0.63%
IXIC9,370.07+1.08 0.01%

Anchiano Therapeutics Q1 EPS $(0.100) Beats $(0.110) Estimate

Anchiano Therapeutics (NASDAQ:ANCN) reported quarterly losses of $(0.100) per share which beat the analyst consensus estimate of $(0.110) by 9.09 percent. This is a 85.71 percent increase over losses of $(0.700) per

Benzinga · 05/11/2020 20:12

Anchiano Therapeutics (NASDAQ:ANCN) reported quarterly losses of $(0.100) per share which beat the analyst consensus estimate of $(0.110) by 9.09 percent. This is a 85.71 percent increase over losses of $(0.700) per share from the same period last year.